const ObjectId = require('mongodb').ObjectId;

module.exports = [
  {
    _id: ObjectId('5e89be73e4b4fc6618217453'),
    status: 'ARCHIVE',
    revision: 1,
    createdByUser: '0000-0002-4115-161X',
    dateCreated: '2020-04-05T11:16:36.049Z',
    dateLastActivity: '2020-04-05T11:16:36.049Z',
    type: 'PROBLEM',
    linkedPublications: [
      '5e83336aca57fb6535f293dc',
    ],
    collaborators: [
      {
        userID: '0000-0002-4115-161X',
        role: 'author',
        status: 'UNCONFIRMED',
      },
    ],
    title: 'Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?',
    summary: 'Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?',
    fundingStatement: 'None',
    coiDeclaration: 'None',
    copyrightLicence: 'CC-BY',
    carriedOut: false,
    text: '<title>tmp/ayne0tfnyu1yvbusddnnm-html.html</title><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><br><style type="text/css">p{margin:0;padding:0}.ft10{font-size:25px;font-family:Times;color:#000}.ft11{font-size:8px;font-family:Times;color:#000}.ft12{font-size:8px;font-family:Times;color:#000}.ft13{font-size:8px;font-family:Times;color:#000}.ft14{font-size:13px;font-family:Times;color:#000}.ft15{font-size:5px;font-family:Times;color:#000}.ft16{font-size:7px;font-family:Times;color:#00539e}.ft17{font-size:7px;font-family:Times;color:#00539e}.ft18{font-size:7px;font-family:Times;color:#000}.ft19{font-size:7px;font-family:Times;color:#4e6a74}.ft110{font-size:3px;font-family:Times;color:#000}.ft111{font-size:8px;font-family:Times;color:#000}.ft112{font-size:7px;font-family:Times;color:#4e6a74}.ft113{font-size:25px;line-height:34px;font-family:Times;color:#000}.ft114{font-size:13px;line-height:19px;font-family:Times;color:#000}.ft115{font-size:7px;line-height:17px;font-family:Times;color:#00539e}.ft116{font-size:7px;line-height:13px;font-family:Times;color:#000}.ft117{font-size:8px;line-height:16px;font-family:Times;color:#000}.ft118{font-size:7px;line-height:12px;font-family:Times;color:#000}</style><div id="page1-div" style="position:relative;width:892px;height:1199px"><p style="position:absolute;top:45px;left:707px;white-space:nowrap" class="ft10"><b>Comment</b></p><p style="position:absolute;top:1159px;left:55px;white-space:nowrap" class="ft11">www.thelancet.com/respiratory&nbsp;<i>&nbsp;&nbsp;</i><b>Published&nbsp;online&nbsp;April 3, 2020 &nbsp; https://doi.org/10.1016/S2213-2600(20)30167-3&nbsp;</b></p><p style="position:absolute;top:1159px;left:841px;white-space:nowrap" class="ft13"><b>1</b></p><p style="position:absolute;top:184px;left:55px;white-space:nowrap" class="ft113"><b>Do&nbsp;chronic&nbsp;respiratory&nbsp;diseases&nbsp;or their treatment&nbsp;affect the&nbsp;<br>risk&nbsp;of SARS-CoV-2 infection?</b></p><p style="position:absolute;top:275px;left:55px;white-space:nowrap" class="ft114">Coronavirus&nbsp;disease 2019 (COVID-19), caused&nbsp;<br>by&nbsp;the novel severe acute respiratory syndrome&nbsp;<br>coronavirus 2 (SARS-CoV-2), is an acute respiratory&nbsp;<br>disease&nbsp;that can lead&nbsp;to respiratory failure and&nbsp;death.1&nbsp;<br>Previous epidemics&nbsp;of novel coronavirus&nbsp;diseases,&nbsp;<br>such as severe acute respiratory syndrome (SARS)&nbsp;<br>and Middle East respiratory syndrome (MERS),&nbsp;were&nbsp;<br>associated&nbsp;with similar clinical features and&nbsp;outcomes.2&nbsp;<br>One might anticipate&nbsp;that patients&nbsp;with chronic&nbsp;<br>respiratory diseases,&nbsp;particularly&nbsp;chronic obstructive&nbsp;<br>pulmonary&nbsp;disease (COPD) and asthma,&nbsp;would be at&nbsp;<br>increased risk&nbsp;of SARS-CoV-2 infection and more severe&nbsp;<br>presentations&nbsp;of&nbsp;COVID-19. However, it is striking&nbsp;that&nbsp;<br>both&nbsp;diseases appear&nbsp;to be&nbsp;under-represented in&nbsp;the&nbsp;<br>comorbidities reported for patients&nbsp;with&nbsp;COVID-19,&nbsp;<br>compared with&nbsp;the&nbsp;global&nbsp;burden of disease&nbsp;estimates&nbsp;<br>of&nbsp;the prevalence&nbsp;of&nbsp;these conditions in&nbsp;the general&nbsp;<br>population (table); a similar pattern&nbsp;was seen&nbsp;with&nbsp;<br>SARS. By contrast,&nbsp;the prevalence&nbsp;of&nbsp;diabetes&nbsp;in&nbsp;<br>patients&nbsp;with&nbsp;COVID-19&nbsp;or SARS is as high as&nbsp;or higher&nbsp;<br>than&nbsp;the estimated national prevalence, as might be&nbsp;<br>expected.</p><p style="position:absolute;top:275px;left:404px;white-space:nowrap" class="ft14">The lower reported prevalence&nbsp;of asthma and&nbsp;COPD in&nbsp;</p><p style="position:absolute;top:295px;left:393px;white-space:nowrap" class="ft114">patients diagnosed with&nbsp;COVID-19&nbsp;might&nbsp;be due&nbsp;to one&nbsp;<br>or a number&nbsp;of factors. First, it is possible&nbsp;that, in contrast&nbsp;<br>to&nbsp;the diagnosis of diabetes,&nbsp;there was&nbsp;substantial&nbsp;<br>underdiagnosis&nbsp;or poor recognition&nbsp;of chronic respiratory&nbsp;<br>disease in patients&nbsp;with&nbsp;COVID-19, particularly in&nbsp;China.&nbsp;<br>However,&nbsp;this seems&nbsp;unlikely, as in very recent&nbsp;data&nbsp;<br>(March&nbsp;23,&nbsp;2020)&nbsp;from&nbsp;Italy,&nbsp;among&nbsp;355&nbsp;patients&nbsp;dying&nbsp;<br>with&nbsp;COVID-19 (mean age 79·5&nbsp;years),&nbsp;diabetes&nbsp;was&nbsp;<br>reported in 20·3%&nbsp;of&nbsp;patients but&nbsp;COPD&nbsp;was&nbsp;not&nbsp;listed&nbsp;<br>as a comorbidity for any patient.3&nbsp;Similarly, provisional&nbsp;<br>data from&nbsp;the&nbsp;USA (March 31, 2020) show&nbsp;that chronic&nbsp;<br>respiratory&nbsp;diseases&nbsp;and&nbsp;diabetes&nbsp;were&nbsp;comorbidities&nbsp;in&nbsp;<br>8·5% and 10·2%&nbsp;of patients&nbsp;with&nbsp;COVID-19, respectively,&nbsp;<br>compared&nbsp;with&nbsp;Global Burden&nbsp;of Disease figures for&nbsp;the&nbsp;<br>population as a&nbsp;whole&nbsp;of 11·3% for chronic respiratory&nbsp;<br>diseases and 10·2% for&nbsp;diabetes; however&nbsp;these&nbsp;data are&nbsp;<br>based&nbsp;on&nbsp;only 7162&nbsp;of&nbsp;the 74&nbsp;439 patients reported.4&nbsp;</p><p style="position:absolute;top:633px;left:404px;white-space:nowrap" class="ft14">A second possibility is&nbsp;that having a chronic respiratory&nbsp;</p><p style="position:absolute;top:653px;left:393px;white-space:nowrap" class="ft114">disease protects against&nbsp;COVID-19, perhaps&nbsp;through&nbsp;<br>a&nbsp;different immune response elicited by&nbsp;the chronic&nbsp;<br>disease itself. However,&nbsp;this&nbsp;theory is not supported by&nbsp;</p><p style="position:absolute;top:280px;left:727px;white-space:nowrap" class="ft116"><i><b>Lancet Respir Med&nbsp;</b></i><b>2020<br></b>Published&nbsp;<b>Online</b>&nbsp;<br>April 3, 2020&nbsp;<br>https://doi.org/10.1016/<br>S2213-2600(20)30167-3</p><p style="position:absolute;top:740px;left:194px;white-space:nowrap" class="ft13"><b>Number of&nbsp;</b></p><p style="position:absolute;top:752px;left:194px;white-space:nowrap" class="ft13"><b>patients</b></p><p style="position:absolute;top:740px;left:265px;white-space:nowrap" class="ft13"><b>Health-care&nbsp;</b></p><p style="position:absolute;top:752px;left:265px;white-space:nowrap" class="ft13"><b>workers (%)</b></p><p style="position:absolute;top:740px;left:345px;white-space:nowrap" class="ft13"><b>Mean&nbsp;or median age&nbsp;</b></p><p style="position:absolute;top:752px;left:345px;white-space:nowrap" class="ft13"><b>(years)</b></p><p style="position:absolute;top:740px;left:442px;white-space:nowrap" class="ft13"><b>Prevalence (%)</b></p><p style="position:absolute;top:769px;left:442px;white-space:nowrap" class="ft11">Chronic&nbsp;</p><p style="position:absolute;top:781px;left:442px;white-space:nowrap" class="ft11">respiratory&nbsp;</p><p style="position:absolute;top:794px;left:442px;white-space:nowrap" class="ft11">disease</p><p style="position:absolute;top:769px;left:516px;white-space:nowrap" class="ft11">COPD</p><p style="position:absolute;top:769px;left:574px;white-space:nowrap" class="ft11">Asthma</p><p style="position:absolute;top:769px;left:640px;white-space:nowrap" class="ft11">Diabetes</p><p style="position:absolute;top:811px;left:68px;white-space:nowrap" class="ft117"><b>Patients&nbsp;with COVID-19<br></b>China12</p><p style="position:absolute;top:828px;left:198px;white-space:nowrap" class="ft11">44&nbsp;672</p><p style="position:absolute;top:828px;left:277px;white-space:nowrap" class="ft11">3·8%</p><p style="position:absolute;top:832px;left:348px;white-space:nowrap" class="ft11">∼51</p><p style="position:absolute;top:828px;left:451px;white-space:nowrap" class="ft11">2·4%</p><p style="position:absolute;top:828px;left:529px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:828px;left:580px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:828px;left:647px;white-space:nowrap" class="ft11">5·3%</p><p style="position:absolute;top:849px;left:68px;white-space:nowrap" class="ft11">Wuhan, China13</p><p style="position:absolute;top:849px;left:210px;white-space:nowrap" class="ft11">140</p><p style="position:absolute;top:849px;left:277px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:849px;left:353px;white-space:nowrap" class="ft11">57*</p><p style="position:absolute;top:849px;left:456px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:849px;left:525px;white-space:nowrap" class="ft11">1·4%</p><p style="position:absolute;top:849px;left:580px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:849px;left:643px;white-space:nowrap" class="ft11">12·1%</p><p style="position:absolute;top:866px;left:68px;white-space:nowrap" class="ft117"><b>Patients with&nbsp;SARS<br></b>Toronto, Canada14</p><p style="position:absolute;top:883px;left:211px;white-space:nowrap" class="ft11">147</p><p style="position:absolute;top:883px;left:272px;white-space:nowrap" class="ft11">51%</p><p style="position:absolute;top:883px;left:353px;white-space:nowrap" class="ft11">45*</p><p style="position:absolute;top:883px;left:456px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:883px;left:525px;white-space:nowrap" class="ft11">1·0%</p><p style="position:absolute;top:883px;left:580px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:883px;left:643px;white-space:nowrap" class="ft11">11·0%</p><p style="position:absolute;top:900px;left:68px;white-space:nowrap" class="ft11">Taipei, Taiwan15</p><p style="position:absolute;top:900px;left:215px;white-space:nowrap" class="ft11">67</p><p style="position:absolute;top:900px;left:272px;white-space:nowrap" class="ft11">37%</p><p style="position:absolute;top:900px;left:354px;white-space:nowrap" class="ft11">51·0</p><p style="position:absolute;top:900px;left:450px;white-space:nowrap" class="ft11">6·0%</p><p style="position:absolute;top:900px;left:529px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:900px;left:580px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:900px;left:642px;white-space:nowrap" class="ft11">23·9%</p><p style="position:absolute;top:917px;left:68px;white-space:nowrap" class="ft11">Kaohsiung, Taiwan16</p><p style="position:absolute;top:917px;left:216px;white-space:nowrap" class="ft11">52</p><p style="position:absolute;top:917px;left:272px;white-space:nowrap" class="ft11">31%</p><p style="position:absolute;top:917px;left:352px;white-space:nowrap" class="ft11">48·1</p><p style="position:absolute;top:917px;left:456px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:917px;left:519px;white-space:nowrap" class="ft11">10·0%</p><p style="position:absolute;top:917px;left:580px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:917px;left:653px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:933px;left:68px;white-space:nowrap" class="ft11">Hong Kong17</p><p style="position:absolute;top:933px;left:215px;white-space:nowrap" class="ft11">88</p><p style="position:absolute;top:933px;left:271px;white-space:nowrap" class="ft11">19%</p><p style="position:absolute;top:933px;left:353px;white-space:nowrap" class="ft11">42·1</p><p style="position:absolute;top:933px;left:456px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:933px;left:524px;white-space:nowrap" class="ft11">0</p><p style="position:absolute;top:933px;left:575px;white-space:nowrap" class="ft11">1·0%</p><p style="position:absolute;top:933px;left:642px;white-space:nowrap" class="ft11">10·0%</p><p style="position:absolute;top:950px;left:68px;white-space:nowrap" class="ft11">Hong Kong18</p><p style="position:absolute;top:950px;left:211px;white-space:nowrap" class="ft11">112</p><p style="position:absolute;top:950px;left:271px;white-space:nowrap" class="ft11">61%</p><p style="position:absolute;top:950px;left:353px;white-space:nowrap" class="ft11">39·3</p><p style="position:absolute;top:950px;left:456px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:950px;left:524px;white-space:nowrap" class="ft11">2·6%</p><p style="position:absolute;top:950px;left:580px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:950px;left:647px;white-space:nowrap" class="ft11">4·5%</p><p style="position:absolute;top:967px;left:68px;white-space:nowrap" class="ft117"><b>General population†<br></b>China19</p><p style="position:absolute;top:984px;left:226px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:984px;left:277px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:984px;left:363px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:984px;left:450px;white-space:nowrap" class="ft11">6·9%</p><p style="position:absolute;top:984px;left:524px;white-space:nowrap" class="ft11">4·9%</p><p style="position:absolute;top:984px;left:575px;white-space:nowrap" class="ft11">2·3%</p><p style="position:absolute;top:984px;left:647px;white-space:nowrap" class="ft11">6·6%</p><p style="position:absolute;top:1001px;left:68px;white-space:nowrap" class="ft11">Canada19</p><p style="position:absolute;top:1001px;left:226px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:1001px;left:277px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:1001px;left:363px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:1001px;left:446px;white-space:nowrap" class="ft11">10·4%</p><p style="position:absolute;top:1001px;left:524px;white-space:nowrap" class="ft11">5·4%</p><p style="position:absolute;top:1001px;left:575px;white-space:nowrap" class="ft11">5·4%</p><p style="position:absolute;top:1001px;left:647px;white-space:nowrap" class="ft11">8·2%</p><p style="position:absolute;top:1018px;left:68px;white-space:nowrap" class="ft11">Taiwan19</p><p style="position:absolute;top:1018px;left:226px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:1018px;left:277px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:1018px;left:363px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:1018px;left:446px;white-space:nowrap" class="ft11">13·1%</p><p style="position:absolute;top:1018px;left:519px;white-space:nowrap" class="ft11">10·4%</p><p style="position:absolute;top:1018px;left:575px;white-space:nowrap" class="ft11">3·9%</p><p style="position:absolute;top:1018px;left:642px;white-space:nowrap" class="ft11">10·6%</p><p style="position:absolute;top:1035px;left:68px;white-space:nowrap" class="ft11">Hong Kong20</p><p style="position:absolute;top:1035px;left:226px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:1035px;left:277px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:1035px;left:363px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:1035px;left:456px;white-space:nowrap" class="ft11">··</p><p style="position:absolute;top:1035px;left:525px;white-space:nowrap" class="ft11">1·4%</p><p style="position:absolute;top:1035px;left:575px;white-space:nowrap" class="ft11">1·9%</p><p style="position:absolute;top:1035px;left:647px;white-space:nowrap" class="ft11">3·8%</p><p style="position:absolute;top:1060px;left:64px;white-space:nowrap" class="ft118">Table references are listed in&nbsp;the appendix.&nbsp;COPD=chronic&nbsp;obstructive pulmonary&nbsp;disease.&nbsp;COVID-19=coronavirus&nbsp;disease 2019. SARS=severe acute respiratory syndrome.&nbsp;<br>*Median age. †Estimates for&nbsp;China,&nbsp;Canada, and&nbsp;Taiwan from&nbsp;the&nbsp;Global Burden&nbsp;of Disease Study; Hong Kong estimates from&nbsp;the Department&nbsp;of Health, Hong Kong Special&nbsp;<br>Administrative&nbsp;Region Government.</p><p style="position:absolute;top:1109px;left:64px;white-space:nowrap" class="ft111"><i><b>Table:&nbsp;</b></i><b>Prevalence&nbsp;of chronic respiratory&nbsp;diseases and&nbsp;diabetes in patients&nbsp;with&nbsp;COVID-19 and SARS</b></p><p style="position:absolute;top:1060px;left:727px;white-space:nowrap" class="ft18">See&nbsp;<b>Online</b>&nbsp;for appendix</p></div><title>tmp/ayne0tfnyu1yvbusddnnm-html.html</title><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><br><style type="text/css">p{margin:0;padding:0}.ft20{font-size:16px;font-family:Times;color:#000}.ft21{font-size:8px;font-family:Times;color:#000}.ft22{font-size:8px;font-family:Times;color:#000}.ft23{font-size:8px;font-family:Times;color:#000}.ft24{font-size:13px;font-family:Times;color:#000}.ft25{font-size:5px;font-family:Times;color:#000}.ft26{font-size:13px;font-family:Times;color:#000}.ft27{font-size:10px;font-family:Times;color:#000}.ft28{font-size:13px;line-height:19px;font-family:Times;color:#000}.ft29{font-size:13px;line-height:23px;font-family:Times;color:#000}.ft210{font-size:8px;line-height:13px;font-family:Times;color:#000}.ft211{font-size:8px;line-height:18px;font-family:Times;color:#000}.ft212{font-size:13px;line-height:18px;font-family:Times;color:#000}.ft213{font-size:10px;line-height:21px;font-family:Times;color:#000}</style><div id="page2-div" style="position:relative;width:892px;height:1199px"><p style="position:absolute;top:54px;left:77px;white-space:nowrap" class="ft20"><b>Comment</b></p><p style="position:absolute;top:1159px;left:43px;white-space:nowrap" class="ft21"><b>2&nbsp;</b></p><p style="position:absolute;top:1159px;left:355px;white-space:nowrap" class="ft22">www.thelancet.com/respiratory&nbsp;<i>&nbsp;&nbsp;</i><b>Published&nbsp;online&nbsp;April 3, 2020 &nbsp; https://doi.org/10.1016/S2213-2600(20)30167-3</b></p><p style="position:absolute;top:196px;left:179px;white-space:nowrap" class="ft28">the finding&nbsp;that among&nbsp;those&nbsp;with&nbsp;COVID-19&nbsp;who have&nbsp;<br>COPD as a comorbidity, mortality is increased,&nbsp;as&nbsp;would&nbsp;<br>otherwise be expected.5</p><p style="position:absolute;top:255px;left:189px;white-space:nowrap" class="ft24">A&nbsp;third possibility&nbsp;is&nbsp;that&nbsp;therapies&nbsp;used by patients&nbsp;</p><p style="position:absolute;top:275px;left:179px;white-space:nowrap" class="ft28">with chronic respiratory&nbsp;diseases can reduce&nbsp;the risk&nbsp;<br>of&nbsp;infection or of developing&nbsp;symptoms&nbsp;leading&nbsp;to&nbsp;<br>diagnosis. It is important&nbsp;to note&nbsp;that, at most,&nbsp;only&nbsp;<br>around half&nbsp;of patients&nbsp;with&nbsp;COPD in&nbsp;China&nbsp;take&nbsp;<br>treatments&nbsp;that are standard in Europe and North&nbsp;<br>America,6&nbsp;but&nbsp;up&nbsp;to 75%&nbsp;of people in&nbsp;China&nbsp;with&nbsp;<br>asthma&nbsp;use inhaled corticosteroids.7&nbsp;Furthermore, in&nbsp;<br>in-vitro&nbsp;models,&nbsp;inhaled&nbsp;corticosteroids&nbsp;alone&nbsp;or&nbsp;in&nbsp;<br>combination&nbsp;with&nbsp;bronchodilators have&nbsp;been shown&nbsp;<br>to suppress coronavirus replication and cytokine&nbsp;<br>production.8,9&nbsp;Low-quality evidence also exists from&nbsp;<br>a case series in Japan, in&nbsp;which improvement&nbsp;was seen&nbsp;<br>in&nbsp;three&nbsp;patients with&nbsp;COVID-19&nbsp;requiring oxygen,&nbsp;<br>but not ventilatory support, after being given inhaled&nbsp;<br>ciclesonide;10&nbsp;however, no control group&nbsp;was&nbsp;used and&nbsp;<br>it is not known&nbsp;whether&nbsp;these patients&nbsp;would have&nbsp;<br>improved&nbsp;spontaneously.&nbsp;Yet, the&nbsp;possibility that&nbsp;<br>inhaled corticosteroids might prevent (at least partly)&nbsp;<br>the development of&nbsp;symptomatic&nbsp;infection or&nbsp;severe&nbsp;<br>presentations&nbsp;of&nbsp;COVID-19 cannot be ignored. By&nbsp;<br>contrast, a systematic review&nbsp;on&nbsp;the&nbsp;use&nbsp;of systemic&nbsp;<br>corticosteroids&nbsp;to&nbsp;treat SARS,&nbsp;once established, showed&nbsp;<br>no benefit but possible harm.11</p><p style="position:absolute;top:732px;left:189px;white-space:nowrap" class="ft24">The potential benefits&nbsp;or harms&nbsp;of inhaled&nbsp;</p><p style="position:absolute;top:752px;left:179px;white-space:nowrap" class="ft28">corticosteroids and&nbsp;other&nbsp;treatments for people at risk&nbsp;<br>of SARS-CoV-2 infection&nbsp;or patients&nbsp;with&nbsp;COVID-19 are&nbsp;<br>unclear at present, and no changes&nbsp;to&nbsp;the&nbsp;treatment&nbsp;<br>or management&nbsp;of chronic respiratory conditions,&nbsp;<br>including&nbsp;COPD and asthma, should be considered at&nbsp;<br>this stage. However, collecting accurate&nbsp;data for&nbsp;the&nbsp;<br>comorbidities and previous&nbsp;therapy&nbsp;of patients&nbsp;with&nbsp;<br>COVID-19&nbsp;will be essential&nbsp;to&nbsp;understanding risk factors&nbsp;<br>for&nbsp;becoming&nbsp;infected,&nbsp;developing&nbsp;symptoms,&nbsp;and&nbsp;being&nbsp;<br>diagnosed, as&nbsp;well as enabling answers&nbsp;to&nbsp;questions&nbsp;<br>about possible benefits&nbsp;or harms&nbsp;of&nbsp;therapy for asthma&nbsp;<br>and&nbsp;COPD&nbsp;during&nbsp;the&nbsp;COVID-19 pandemic.&nbsp;This could be&nbsp;</p><p style="position:absolute;top:196px;left:517px;white-space:nowrap" class="ft211">achieved&nbsp;using a standard&nbsp;dataset as advocated by&nbsp;WHO,&nbsp;<br>including information about&nbsp;the presence and severity&nbsp;<br>of comorbidities and all medication&nbsp;that&nbsp;was being&nbsp;<br>taken&nbsp;at the time&nbsp;of&nbsp;infection.<br>DMGH has received personal fees from&nbsp;AstraZeneca, Boehringer Ingelheim,&nbsp;<br>Chiesi,&nbsp;GlaxoSmithKline, Novartis, Pfizer, and Sanofi, and non-financial support&nbsp;<br>from Boehringer Ingelheim and Novartis,&nbsp;outside&nbsp;of&nbsp;the submitted&nbsp;work. RF has&nbsp;<br>received grants from&nbsp;GlaxoSmithKline and Menarini,&nbsp;outside&nbsp;of&nbsp;the submitted&nbsp;<br>work.&nbsp;AA has received grants from&nbsp;AstraZeneca,&nbsp;GlaxoSmithKline, and Menarini,&nbsp;<br>and personal fees from&nbsp;AstraZeneca,&nbsp;Chiesi,&nbsp;GlaxoSmithKline, and Menarini,&nbsp;<br>outside&nbsp;of&nbsp;the submitted&nbsp;work.&nbsp;OS and JRB&nbsp;declare no competing interests.&nbsp;<br><i>*David M&nbsp;G Halpin, Rosa Faner,&nbsp;Oriol Sibila,&nbsp;</i></p><p style="position:absolute;top:393px;left:517px;white-space:nowrap" class="ft211"><i>Joan Ramon Badia, Alvar Agusti<br></i><b>d.halpin@nhs.net&nbsp;<br></b>University&nbsp;of Exeter Medical School,&nbsp;College&nbsp;of Medicine and Health,&nbsp;University&nbsp;of&nbsp;<br>Exeter, Exeter EX1 2LU,&nbsp;UK (DMGH); Respiratory Institute, Hospital&nbsp;Clinic,&nbsp;August&nbsp;<br>Pi i Sunyer Biomedical Research Institute,&nbsp;University&nbsp;of Barcelona and National&nbsp;<br>Spanish Network for Respiratory Research, Barcelona, Spain (RF,&nbsp;OS, JRB,&nbsp;AA)<br>1&nbsp;</p><p style="position:absolute;top:491px;left:538px;white-space:nowrap" class="ft22">Huang&nbsp;C,&nbsp;Wang&nbsp;Y, Li&nbsp;X, et al.&nbsp;Clinical features&nbsp;of patients infected&nbsp;with 2019&nbsp;</p><p style="position:absolute;top:503px;left:538px;white-space:nowrap" class="ft22">novel coronavirus in&nbsp;Wuhan,&nbsp;China.&nbsp;<i>Lancet</i>&nbsp;2020;&nbsp;<b>395:</b>&nbsp;497–506.</p><p style="position:absolute;top:517px;left:517px;white-space:nowrap" class="ft22">2&nbsp;</p><p style="position:absolute;top:517px;left:538px;white-space:nowrap" class="ft22">Yin&nbsp;Y,&nbsp;Wunderink RG. MERS, SARS and&nbsp;other coronaviruses as causes&nbsp;of&nbsp;</p><p style="position:absolute;top:529px;left:538px;white-space:nowrap" class="ft22">pneumonia.&nbsp;<i>Respirology</i>&nbsp;2018;&nbsp;<b>23:</b>&nbsp;130–37.</p><p style="position:absolute;top:543px;left:517px;white-space:nowrap" class="ft22">3&nbsp;</p><p style="position:absolute;top:543px;left:538px;white-space:nowrap" class="ft22">Onder&nbsp;G, Rezza&nbsp;G, Brusaferro S.&nbsp;Case-fatality rate and characteristics&nbsp;of&nbsp;</p><p style="position:absolute;top:555px;left:538px;white-space:nowrap" class="ft22">patients&nbsp;dying in relation&nbsp;to&nbsp;COVID-19 in Italy.&nbsp;<i>JAMA</i>&nbsp;2020; published&nbsp;</p><p style="position:absolute;top:567px;left:538px;white-space:nowrap" class="ft22">online March 23. DOI:10.1001/jama.2020.4683.</p><p style="position:absolute;top:581px;left:517px;white-space:nowrap" class="ft22">4&nbsp;</p><p style="position:absolute;top:581px;left:538px;white-space:nowrap" class="ft22">CDC&nbsp;COVID-19 Response&nbsp;Team. Preliminary estimates&nbsp;of&nbsp;the prevalence&nbsp;of&nbsp;</p><p style="position:absolute;top:593px;left:538px;white-space:nowrap" class="ft22">selected&nbsp;underlying health conditions among patients&nbsp;with coronavirus&nbsp;</p><p style="position:absolute;top:605px;left:538px;white-space:nowrap" class="ft22">disease 2019 —&nbsp;United States, February 12–March 28, 2020. 2020.&nbsp;</p><p style="position:absolute;top:617px;left:538px;white-space:nowrap" class="ft22">https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6913e2-H.pdf&nbsp;</p><p style="position:absolute;top:629px;left:538px;white-space:nowrap" class="ft22">(accessed&nbsp;April 2, 2020).</p><p style="position:absolute;top:644px;left:517px;white-space:nowrap" class="ft22">5&nbsp;</p><p style="position:absolute;top:644px;left:538px;white-space:nowrap" class="ft22">The Novel&nbsp;Coronavirus Pneumonia Emergency Response Epidemiology&nbsp;</p><p style="position:absolute;top:656px;left:538px;white-space:nowrap" class="ft22">Team.&nbsp;The epidemiological characteristics&nbsp;of an&nbsp;outbreak&nbsp;of 2019 novel&nbsp;</p><p style="position:absolute;top:668px;left:538px;white-space:nowrap" class="ft22">coronavirus&nbsp;diseases (COVID-19)—China, 2020.&nbsp;<i>China&nbsp;CDC Weekly</i>&nbsp;2020;&nbsp;</p><p style="position:absolute;top:680px;left:538px;white-space:nowrap" class="ft21"><b>2:</b>&nbsp;113–22.</p><p style="position:absolute;top:694px;left:517px;white-space:nowrap" class="ft22">6&nbsp;</p><p style="position:absolute;top:694px;left:538px;white-space:nowrap" class="ft22">Liu&nbsp;Y, Liu&nbsp;G,&nbsp;Wu H, Jian&nbsp;W,&nbsp;Wild SH,&nbsp;Gasevic D. Sex&nbsp;differences in non-</p><p style="position:absolute;top:706px;left:538px;white-space:nowrap" class="ft22">communicable&nbsp;disease prevalence in&nbsp;China: a cross-sectional analysis&nbsp;of&nbsp;the&nbsp;</p><p style="position:absolute;top:718px;left:538px;white-space:nowrap" class="ft22">China Health and Retirement Longitudinal Study in 2011.&nbsp;<i>BMJ Open</i>&nbsp;2017;&nbsp;</p><p style="position:absolute;top:730px;left:538px;white-space:nowrap" class="ft21"><b>7:</b>&nbsp;e017450.</p><p style="position:absolute;top:744px;left:517px;white-space:nowrap" class="ft22">7&nbsp;</p><p style="position:absolute;top:744px;left:538px;white-space:nowrap" class="ft22">Su N, Lin J,&nbsp;Chen P, et al. Evaluation&nbsp;of asthma control and patient’s&nbsp;</p><p style="position:absolute;top:756px;left:538px;white-space:nowrap" class="ft22">perception&nbsp;of asthma: findings and analysis&nbsp;of a nationwide&nbsp;questionnaire-</p><p style="position:absolute;top:768px;left:538px;white-space:nowrap" class="ft22">based survey in&nbsp;China.&nbsp;<i>J Asthma</i>&nbsp;2013;&nbsp;<b>50:</b>&nbsp;861–70.</p><p style="position:absolute;top:782px;left:517px;white-space:nowrap" class="ft22">8&nbsp;</p><p style="position:absolute;top:782px;left:538px;white-space:nowrap" class="ft22">Yamaya M, Nishimura H, Deng&nbsp;X, et al. Inhibitory effects&nbsp;of&nbsp;</p><p style="position:absolute;top:794px;left:538px;white-space:nowrap" class="ft22">glycopyrronium, formoterol, and budesonide&nbsp;on coronavirus HCoV-229E&nbsp;</p><p style="position:absolute;top:806px;left:538px;white-space:nowrap" class="ft22">replication and cytokine production by primary cultures&nbsp;of human nasal&nbsp;</p><p style="position:absolute;top:818px;left:538px;white-space:nowrap" class="ft22">and&nbsp;tracheal epithelial cells.&nbsp;<i>Respir Investig</i>&nbsp;2020; published&nbsp;online Feb 21.&nbsp;</p><p style="position:absolute;top:830px;left:538px;white-space:nowrap" class="ft22">DOI:10.1016/j.resinv.2019.12.005.</p><p style="position:absolute;top:844px;left:517px;white-space:nowrap" class="ft22">9&nbsp;</p><p style="position:absolute;top:844px;left:538px;white-space:nowrap" class="ft22">Matsuyama S, Kawase M, Nao N, et al.&nbsp;The inhaled corticosteroid&nbsp;</p><p style="position:absolute;top:856px;left:538px;white-space:nowrap" class="ft22">ciclesonide blocks coronavirus RNA replication by&nbsp;targeting viral NSP15.&nbsp;</p><p style="position:absolute;top:868px;left:538px;white-space:nowrap" class="ft23"><i>bioRxiv</i>&nbsp;2020; published&nbsp;online March 12. DOI:10.1101/2020.03.11.987016&nbsp;</p><p style="position:absolute;top:880px;left:538px;white-space:nowrap" class="ft22">(preprint).</p><p style="position:absolute;top:894px;left:517px;white-space:nowrap" class="ft22">10&nbsp;&nbsp;Iwabuchi K,&nbsp;Yoshie K, Kurakami&nbsp;Y,&nbsp;Takahashi K, Kato&nbsp;Y. Morishima&nbsp;T.&nbsp;</p><p style="position:absolute;top:906px;left:538px;white-space:nowrap" class="ft22">COVID-19.&nbsp;Three cases improved&nbsp;with inhaled ciclesonide in&nbsp;the early&nbsp;to&nbsp;</p><p style="position:absolute;top:918px;left:538px;white-space:nowrap" class="ft22">middle stages&nbsp;of pneumonia. 2020. http://www.kansensho.or.jp/uploads/</p><p style="position:absolute;top:930px;left:538px;white-space:nowrap" class="ft22">files/topics/2019ncov/covid19_casereport_200310.pdf (accessed&nbsp;</p><p style="position:absolute;top:942px;left:538px;white-space:nowrap" class="ft22">March&nbsp;27, 2020; in Japanese).</p><p style="position:absolute;top:956px;left:517px;white-space:nowrap" class="ft22">11&nbsp;&nbsp;Stockman LJ, Bellamy R,&nbsp;Garner P. SARS: systematic review&nbsp;of&nbsp;treatment&nbsp;</p><p style="position:absolute;top:968px;left:538px;white-space:nowrap" class="ft22">effects.&nbsp;<i>PLoS Med</i>&nbsp;2006;&nbsp;<b>3:</b>&nbsp;e343.</p></div>',
    fileId: '',
    publicationID: '5e89be14e4b4fc6618217452',
  },
  {
    _id: ObjectId('5e8a3b7ee4b4fc661821745f'),
    status: 'ARCHIVE',
    revision: 1,
    createdByUser: '0000-0002-4115-161X',
    dateCreated: '2020-04-05T20:06:55.086Z',
    dateLastActivity: '2020-04-05T20:06:55.086Z',
    type: 'INTERPRETATION',
    linkedPublications: [
      '5e8a3945e4b4fc661821745d',
    ],
    collaborators: [
      {
        userID: '0000-0002-4115-161X',
        role: 'author',
        status: 'UNCONFIRMED',
      },
    ],
    title: 'Hypertension is therein risk factor, other than age, for COVID-19',
    summary: 'Ameta-analysis reveals the patterns of co-morbidity in COVID-19 cases',
    fundingStatement: 'None',
    coiDeclaration: 'None',
    copyrightLicence: 'CC-BY',
    carriedOut: false,
    text: '<p>The meta-analysis was based on data from 8 studies with laboratory- confirmed COVID -19. All the cases were from hospitals in China. The result we observed more men than women, statistics about 23871:22377 in the COVID-19 infection. </p><p>MERS-CoV and SARS- CoV have also been found to infect more males than females men, partly because of their more robust innate and adaptive immune responses. It&nbsp;is customary to think women are less likely to affect many bacteria and viruses than men.&nbsp;However, it may be related to the occupational risk factors for men in Huanan wet&nbsp;market exposure history in Huang’s report. Aged people and severe patients aremore susceptible to COVID-19, this may be associated with a higher frequency of&nbsp;comorbidities .</p><p>A meta-analysis of the comorbidities suggests that hypertension prevalent in approximately 17% of the patients, diabetes, cardiovascular diseases, and respiratory system disease were present in 8%, 5%, and 2% of the cases, respectively. Hypertension, diabetes mellitus consistent with the prevalence of hypertension and diabetes in China were 23.2%14&nbsp;and 10.9%15&nbsp;in adults. A recent study about influenza illness suggested that compared to patients with no comorbidities, the risk of death for severe patients more often in those who had chronic obstructive pulmonary disease (OR 1.49, 95% CI: 1.10-2.01), and in those who had cardiovascular disease(OR 2.92,1695% CI: 1.76-4.86 ), hypertension(OR 1.49,95% CI: 1.10-2.10) . The comorbiditieseffect had also been noted to have similar effects in other respiratory illnesses, such as11. In our study, the association also showed in hypertension, cardiovascular diseases, and respiratory system disease group. Overall, the severe patients were older&nbsp;4&nbsp;and had a more significant number of comorbid conditions than those Non-severe. These results suggest that age and comorbidities may be risk factors for critical patients.The diseases such as hypertension, diabetes, respiratory system disease, cardiovascular diseases, and their susceptibility conditions, may be linked to the pathogenesis of COVID-19. Chronic diseases share several standard features with infectious disorders, such as the proinflammatory state, and the attenuation of the innate immune response. For instance, diabetes occurs in part because the accumulation of activated innate immune cells in metabolic tissues leads to the release of inflammatory mediators, especially, IL-1β and TNFα, which promotes systemic17immune function by impairing macrophage and lymphocyte function11retrospectively analyzed the clinical data of patients with viral pneumonia and foundinsulin resistance and&nbsp;β-cell damage. Besides, metabolic disorders may lead to lowmake individuals more susceptible to disease complications. Recently, Guo et al1918, which may6Journal Pre-proofthat the absolute count levels of CD3+ T cell, CD3+ CD8+ T cell and CD3+ CD4+ T cell in the death group were significantly lower than those in the survival group, suggesting that the levels of various inflammatory factors in the death group were higher than those in the survival group. A prospective case control study about20seasonal influenza was conducted by Hong et aland chronic cardiovascular disease were significantly related to development of complications, and diabetes was an independent risk factor for severe seasonal influenza (odds ration OR: 3.63, 95% CI(1.15-11.51)，P=0.02). Furthermore, a study analyzed the risk factors for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) patients, finding diabetes, Smoking, and heart disease were alsosignificantly associated with MERS-CoV illnessLimitations of this meta-analysis should be addressed. First, the high statistic heterogeneity could be found. This may relate to the study designs and large variation among studies in the sample size (9 to 46248 patients). Second, different lengths of follow-up may miss the event leading to heterogeneity. Owing to some patients are still in hospital in the included studies. Third, because only a few studies comparedthe comorbidities of severe and Non-severe patients, we did not conduct sensitivity analysis and subgroup analysis.If causality exists between chronic diseases and COVID-19, it will help the health sector guide vulnerable populations and assess the risk of deterioration. Lau et al&nbsp;22&nbsp;followed up the vaccinations of 91,605 people with diabetes, the results showed that the flu vaccine could make the incidence of influenza and pneumonia in people with diabetes aged (&lt;65 years) decreased by 43%, and diabetes in the elderly (≥65 years)&nbsp;people fell 55%. The symptoms of COVID-19 are similar with those of influenza (e. g, fever, cough or fatigue), and outbreaks occur during the year of a high prevalence of respiratory diseases caused by influenza, respiratory syncytial virus, and other respiratory viruses. Vaccines can still be useful in helping prevent flu and will reduce possible confusion with the COVID-19 infection.</p><p>Hypertension, diabetes, respiratory system disease, and cardiovascular disease period were identified as potentially important risk factors that should be included in future&nbsp;vaccination recommendations. Given the limited level of evidence, more adequately and powered study should be conducted to prove the association.&nbsp;</p>',
    publicationID: '5e8a3a5fe4b4fc661821745e',
  },
  {
    _id: ObjectId('5e8b16f7e4b4fc6618217460'),
    type: 'PROBLEM',
    status: 'ARCHIVE',
    parentProblems: [
      '0',
    ],
    parentPublications: [
      '0',
    ],
    revision: 1,
    title: 'Democratisation of science publishing',
    summary: 'Science publishing is broken. Octopus aims to fix it.',
    text: 'In this publication we will explore current challenges with science publishing and explore Octopus as a solution to these problems.',
    fundingStatement: '',
    coiDeclaration: '',
    createdByUser: '0000-0000-0000-0000',
    dateCreated: '2019-09-01 00:00:00.000',
    dateLastActivity: '2019-09-01 00:00:00.000',
    keywords: [],
    collaborators: [
      {
        userID: '0000-0000-0000-0000',
        role: 'author',
        status: 'CONFIRMED',
        dateAdded: '2019-09-01 00:00:00.000',
      },
    ],
    ratings: {
      '0000-0002-7877-0000': [
        4,
        5,
        5,
      ],
    },
    publicationID: '5e83336aca57fb6535f293da',
  },
  {
    _id: ObjectId('5e94ade35706eb67777ae95b'),
    status: 'ARCHIVE',
    revision: 2,
    createdByUser: '0000-0002-4115-161X',
    dateCreated: '2020-04-05T11:18:11.505Z',
    dateLastActivity: '2020-04-05T11:18:11.505Z',
    type: 'PROBLEM',
    linkedPublications: [
      '5e83336aca57fb6535f293dc',
    ],
    collaborators: [
      {
        userID: '0000-0002-4115-161X',
        role: 'author',
        status: 'UNCONFIRMED',
      },
    ],
    title: 'Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?',
    summary: 'Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?',
    fundingStatement: 'None',
    coiDeclaration: 'None',
    copyrightLicence: 'CC-BY',
    carriedOut: false,
    text: '<p><strong>Do&nbsp;chronic&nbsp;respiratory&nbsp;diseases&nbsp;or their treatment&nbsp;affect the&nbsp;risk&nbsp;of SARS-CoV-2 infection?</strong></p><p>Coronavirus&nbsp;disease 2019 (COVID-19), caused by&nbsp;the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an acute respiratory&nbsp;disease&nbsp;that can lead&nbsp;to respiratory failure and&nbsp;death.&nbsp;Previous epidemics&nbsp;of novel coronavirus&nbsp;diseases,&nbsp;such as severe acute respiratory syndrome (SARS)&nbsp;and Middle East respiratory syndrome (MERS),&nbsp;were&nbsp;associated&nbsp;with similar clinical features and&nbsp;outcomes.&nbsp;One might anticipate&nbsp;that patients&nbsp;with chronic&nbsp;respiratory diseases,&nbsp;particularly&nbsp;chronic obstructive&nbsp;pulmonary&nbsp;disease (COPD) and asthma,&nbsp;would be at&nbsp;increased risk&nbsp;of SARS-CoV-2 infection and more severe&nbsp;presentations&nbsp;of&nbsp;COVID-19.</p><title>tmp/ayne0tfnyu1yvbusddnnm-html.html</title><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><style type="text/css">p{margin:0;padding:0}.ft20{font-size:16px;font-family:Times;color:#000}.ft21{font-size:8px;font-family:Times;color:#000}.ft22{font-size:8px;font-family:Times;color:#000}.ft23{font-size:8px;font-family:Times;color:#000}.ft24{font-size:13px;font-family:Times;color:#000}.ft25{font-size:5px;font-family:Times;color:#000}.ft26{font-size:13px;font-family:Times;color:#000}.ft27{font-size:10px;font-family:Times;color:#000}.ft28{font-size:13px;line-height:19px;font-family:Times;color:#000}.ft29{font-size:13px;line-height:23px;font-family:Times;color:#000}.ft210{font-size:8px;line-height:13px;font-family:Times;color:#000}.ft211{font-size:8px;line-height:18px;font-family:Times;color:#000}.ft212{font-size:13px;line-height:18px;font-family:Times;color:#000}.ft213{font-size:10px;line-height:21px;font-family:Times;color:#000}</style><div id="page2-div" style="position:relative;width:892px;height:1199px"><br><p style="position:absolute;top:968px;left:538px;white-space:nowrap" class="ft22">.</p></div><style type="text/css">p{margin:0;padding:0}.ft10{font-size:25px;font-family:Times;color:#000}.ft11{font-size:8px;font-family:Times;color:#000}.ft12{font-size:8px;font-family:Times;color:#000}.ft13{font-size:8px;font-family:Times;color:#000}.ft14{font-size:13px;font-family:Times;color:#000}.ft15{font-size:5px;font-family:Times;color:#000}.ft16{font-size:7px;font-family:Times;color:#00539e}.ft17{font-size:7px;font-family:Times;color:#00539e}.ft18{font-size:7px;font-family:Times;color:#000}.ft19{font-size:7px;font-family:Times;color:#4e6a74}.ft110{font-size:3px;font-family:Times;color:#000}.ft111{font-size:8px;font-family:Times;color:#000}.ft112{font-size:7px;font-family:Times;color:#4e6a74}.ft113{font-size:25px;line-height:34px;font-family:Times;color:#000}.ft114{font-size:13px;line-height:19px;font-family:Times;color:#000}.ft115{font-size:7px;line-height:17px;font-family:Times;color:#00539e}.ft116{font-size:7px;line-height:13px;font-family:Times;color:#000}.ft117{font-size:8px;line-height:16px;font-family:Times;color:#000}.ft118{font-size:7px;line-height:12px;font-family:Times;color:#000}</style>',
    fileId: '',
    ratings: [],
    keywords: [],
    publicationID: '5e89be14e4b4fc6618217452',
  },
  {
    _id: ObjectId('5e94b9c85706eb67777ae96a'),
    status: 'ARCHIVE',
    revision: 1,
    createdByUser: '0000-0002-4115-161X',
    dateCreated: '2020-04-13T19:11:34.005Z',
    dateLastActivity: '2020-04-13T19:11:34.005Z',
    type: 'PROBLEM',
    linkedPublications: [
      '5e94b9145706eb67777ae967',
    ],
    collaborators: [
      {
        userID: '0000-0002-4115-161X',
        role: 'author',
        status: 'UNCONFIRMED',
      },
    ],
    title: 'Meta-analysis of studies reporting R0 for COVID-19',
    fundingStatement: 'None',
    coiDeclaration: 'None',
    copyrightLicence: 'CC-BY',
    carriedOut: false,
    text: '<p style="font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; margin: 0px 0px 1rem; padding: 0px; border: 0px; font-family: Merriweather, serif; font-size: 0.9375rem; font-stretch: inherit; line-height: 1.7em; vertical-align: baseline; caret-color: rgb(42, 42, 42); color: rgb(42, 42, 42);">The first studies initially reported estimates of<span class="Apple-converted-space">&nbsp;</span><em style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: italic; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline;">R</em><sub style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: 0.75rem; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: normal; vertical-align: sub;">0</sub><span class="Apple-converted-space">&nbsp;</span>with lower values. Estimations subsequently increased and then again returned in the most recent estimates to the levels initially reported (Figure 1). A closer look reveals that the estimation method used played a role.</p><p style="font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; margin: 0px 0px 1rem; padding: 0px; border: 0px; font-family: Merriweather, serif; font-size: 0.9375rem; font-stretch: inherit; line-height: 1.7em; vertical-align: baseline; caret-color: rgb(42, 42, 42); color: rgb(42, 42, 42);">The two studies using stochastic methods to estimate<span class="Apple-converted-space">&nbsp;</span><em style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: italic; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline;">R</em><sub style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: 0.75rem; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: normal; vertical-align: sub;">0</sub>, reported a range of 2.2–2.68 with an average of 2.44.<a reveal-id="ref1" data-open="ref1" class="link link-ref link-reveal xref-bibr" style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline; color: rgb(0, 111, 183); text-decoration: none; overflow-wrap: break-word; word-wrap: break-word; word-break: break-word; -webkit-hyphens: auto;"><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">1</sup></a><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">,</sup><a reveal-id="ref9" data-open="ref9" class="link link-ref link-reveal xref-bibr" style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline; color: rgb(0, 111, 183); text-decoration: none; overflow-wrap: break-word; word-wrap: break-word; word-break: break-word; -webkit-hyphens: auto;"><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">9</sup></a><span class="Apple-converted-space">&nbsp;</span>The six studies using mathematical methods to estimate<span class="Apple-converted-space">&nbsp;</span><em style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: italic; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline;">R</em><sub style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: 0.75rem; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: normal; vertical-align: sub;">0</sub><span class="Apple-converted-space">&nbsp;</span>produced a range from 1.5 to 6.49, with an average of 4.2.<a reveal-id="ref2" data-open="ref2" class="link link-ref link-reveal xref-bibr" style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline; color: rgb(0, 111, 183); text-decoration: none; overflow-wrap: break-word; word-wrap: break-word; word-break: break-word; -webkit-hyphens: auto;"><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">2</sup></a><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">,</sup><a reveal-id="ref4 ref5 ref6" data-open="ref4 ref5 ref6" class="link link-ref link-reveal xref-bibr" style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline; color: rgb(0, 111, 183); text-decoration: none; overflow-wrap: break-word; word-wrap: break-word; word-break: break-word; -webkit-hyphens: auto;"><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">4–6</sup></a><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">,</sup><a reveal-id="ref8" data-open="ref8" class="link link-ref link-reveal xref-bibr" style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline; color: rgb(0, 111, 183); text-decoration: none; overflow-wrap: break-word; word-wrap: break-word; word-break: break-word; -webkit-hyphens: auto;"><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">8</sup></a><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">,</sup><a reveal-id="ref10" data-open="ref10" class="link link-ref link-reveal xref-bibr" style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline; color: rgb(0, 111, 183); text-decoration: none; overflow-wrap: break-word; word-wrap: break-word; word-break: break-word; -webkit-hyphens: auto;"><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">10</sup></a><span class="Apple-converted-space">&nbsp;</span>The three studies using statistical methods such as exponential growth estimated an<span class="Apple-converted-space">&nbsp;</span><em style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: italic; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline;">R</em><sub style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: 0.75rem; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: normal; vertical-align: sub;">0</sub>ranging from 2.2 to 3.58, with an average of 2.67.<a reveal-id="ref3" data-open="ref3" class="link link-ref link-reveal xref-bibr" style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline; color: rgb(0, 111, 183); text-decoration: none; overflow-wrap: break-word; word-wrap: break-word; word-break: break-word; -webkit-hyphens: auto;"><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">3</sup></a><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">,</sup><a reveal-id="ref7" data-open="ref7" class="link link-ref link-reveal xref-bibr" style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline; color: rgb(0, 111, 183); text-decoration: none; overflow-wrap: break-word; word-wrap: break-word; word-break: break-word; -webkit-hyphens: auto;"><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">7</sup></a><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">,</sup><a reveal-id="ref11" data-open="ref11" class="link link-ref link-reveal xref-bibr" style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline; color: rgb(0, 111, 183); text-decoration: none; overflow-wrap: break-word; word-wrap: break-word; word-break: break-word; -webkit-hyphens: auto;"><sup style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: &quot;Source Sans Pro&quot;, sans-serif; font-size: 0.75em; font-style: inherit; font-variant-caps: inherit; font-weight: normal; font-stretch: inherit; line-height: normal; vertical-align: baseline; position: relative; top: -0.75em;">11</sup></a></p><br class="Apple-interchange-newline"><p style="font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; margin: 0px 0px 1rem; padding: 0px; border: 0px; font-family: Merriweather, serif; font-size: 0.9375rem; font-stretch: inherit; line-height: 1.7em; vertical-align: baseline; caret-color: rgb(42, 42, 42); color: rgb(42, 42, 42);">Our review found the average<span class="Apple-converted-space">&nbsp;</span><em style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: italic; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline;">R</em><sub style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: 0.75rem; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: normal; vertical-align: sub;">0</sub><span class="Apple-converted-space">&nbsp;</span>to be 3.28 and median to be 2.79, which exceed WHO estimates from 1.4 to 2.5. The studies using stochastic and statistical methods for deriving<span class="Apple-converted-space">&nbsp;</span><em style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: italic; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline;">R</em><sub style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: 0.75rem; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: normal; vertical-align: sub;">0</sub><span class="Apple-converted-space">&nbsp;</span>provide estimates that are reasonably comparable. However, the studies using mathematical methods produce estimates that are, on average, higher. Some of the mathematically derived estimates fall within the range produced the statistical and stochastic estimates. It is important to further assess the reason for the higher<span class="Apple-converted-space">&nbsp;</span><em style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: italic; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline;">R</em><sub style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: 0.75rem; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: normal; vertical-align: sub;">0</sub><span class="Apple-converted-space">&nbsp;</span>values estimated by some the mathematical studies. For example, modelling assumptions may have played a role. In more recent studies,<span class="Apple-converted-space">&nbsp;</span><em style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: italic; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline;">R</em><sub style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: 0.75rem; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: normal; vertical-align: sub;">0</sub><span class="Apple-converted-space">&nbsp;</span>seems to have stabilized at around 2–3.<span class="Apple-converted-space">&nbsp;</span><em style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: italic; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline;">R</em><sub style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: 0.75rem; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: normal; vertical-align: sub;">0</sub><span class="Apple-converted-space">&nbsp;</span>estimations produced at later stages can be expected to be more reliable, as they build upon more case data and include the effect of awareness and intervention. It is worthy to note that the WHO point estimates are consistently below all published estimates, although the higher end of the WHO range includes the lower end of the estimates reviewed here.</p><p style="font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; margin: 0px 0px 1rem; padding: 0px; border: 0px; font-family: Merriweather, serif; font-size: 0.9375rem; font-stretch: inherit; line-height: 1.7em; vertical-align: baseline; caret-color: rgb(42, 42, 42); color: rgb(42, 42, 42);"><em style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: italic; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline;">R</em><sub style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: 0.75rem; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: normal; vertical-align: sub;">0</sub><span class="Apple-converted-space">&nbsp;</span>estimates for SARS have been reported to range between 2 and 5, which is within the range of the mean<span class="Apple-converted-space">&nbsp;</span><em style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: inherit; font-style: italic; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; vertical-align: baseline;">R</em><sub style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; font-family: inherit; font-size: 0.75rem; font-style: inherit; font-variant-caps: inherit; font-weight: inherit; font-stretch: inherit; line-height: normal; vertical-align: sub;">0</sub><span class="Apple-converted-space">&nbsp;</span>for COVID-19 found in this review. Due to similarities of both pathogen and region of exposure, this is expected. On the other hand, despite the heightened public awareness and impressively strong interventional response, the COVID-19 is already more widespread than SARS, indicating it may be more transmissible.</p><br class="Apple-interchange-newline" style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; text-decoration: none;"><br class="Apple-interchange-newline">',
    publicationID: '5e94b9665706eb67777ae968',
  },
  {
    _id: ObjectId('5e94bc9e5706eb67777ae96f'),
    status: 'ARCHIVE',
    revision: 1,
    createdByUser: '0000-0002-4115-161X',
    dateCreated: '2020-04-13T19:25:06.443Z',
    dateLastActivity: '2020-04-13T19:25:06.443Z',
    type: 'PROBLEM',
    linkedPublications: [
      '5e94aaae577b8a88890bc805',
    ],
    collaborators: [
      {
        userID: '0000-0002-4115-161X',
        role: 'author',
        status: 'UNCONFIRMED',
      },
    ],
    title: 'How can we model the epidemiology of COVID-19?',
    fundingStatement: 'None',
    coiDeclaration: 'None',
    copyrightLicence: 'CC-BY',
    carriedOut: false,
    text: 'Only by studying the epidemiology of COVID-19 can we understand how it is spread, and what the risk factors for infection might be.',
    publicationID: '5e94bc925706eb67777ae96d',
  },
  {
    _id: ObjectId('5e96bb4f5706eb67777ae970'),
    status: 'ARCHIVE',
    revision: 1,
    createdByUser: '0000-0002-4115-161X',
    dateCreated: '2020-04-13T17:03:13.661Z',
    dateLastActivity: '2020-04-13T17:03:13.661Z',
    type: 'PROBLEM',
    linkedPublications: [
      '5e83336aca57fb6535f293dc',
    ],
    collaborators: [
      {
        userID: '0000-0002-4115-161X',
        role: 'author',
        status: 'UNCONFIRMED',
      },
    ],
    title: 'Open and Fast access to epidemiological data during the COVID-19 outbreak',
    fundingStatement: 'None',
    coiDeclaration: 'None',
    copyrightLicence: 'CC-BY',
    carriedOut: false,
    text: '<span style="font-size: 12px; font-family: Arial, Helvetica, sans-serif;">Coronavirus disease 2019 (COVID-19) is spreading rapidly across China, and as of Feb 16, 2020, had been reported in 26 countries globally. The availability of accurate and robust epidemiological, clinical, and laboratory data early in an epidemic is important to guide public health decision-making.<div class="dropBlock reference-citations" style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; display: inline; position: relative;"><p style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; display: inline; position: relative;"><br></p></div><p style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; display: inline; position: relative;"><br></p><div class="dropBlock reference-citations" style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; display: inline; position: relative;">Consistent recording of epidemiological information is important to understand transmissibility, risk of geographic spread, routes of transmission, and risk factors for infection, and to provide the baseline for epidemiological modelling that can inform planning of response and containment efforts to reduce the burden of disease. Furthermore, detailed information provided in real time is crucial for deciding where to prioritise surveillance.<p style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; display: inline; position: relative;"><br></p></div><p style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; display: inline; position: relative;"><br></p></span><div class="section-paragraph" style="font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; margin-top: 10px; margin-bottom: 18px; caret-color: rgb(80, 80, 80); color: rgb(80, 80, 80); font-family: " source="" sans="" pro",="" sans-serif;="" font-size:="" 18px;"=""><span style="font-size: 12px; font-family: Arial, Helvetica, sans-serif;">Line list data are rarely available openly in real time during outbreaks. However, they enable a multiplicity of analyses to be undertaken by different groups, using various models and assumptions, which can help build consensus on robust inference. Parallels exist between this and the open sharing of genomic data.</span><div class="dropBlock reference-citations" style="box-sizing: border-box; display: inline; position: relative;"><sup style="box-sizing: border-box; line-height: 0; position: relative; vertical-align: baseline; top: -0.5em; font-size: 13.5px;"><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30119-5/fulltext#bib2" id="back-bib2" data-db-target-for="bib2-d3353096e170" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib2" style="box-sizing: border-box; background-color: transparent; text-decoration-skip: objects; cursor: pointer; color: rgb(0, 84, 158); text-decoration: none; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: rgb(235, 235, 235);"></a></sup></div></div>',
    keywords: [],
    publicationID: '5e949b515706eb67777ae954',
  },
  {
    _id: ObjectId('5e96bc645706eb67777ae971'),
    status: 'ARCHIVE',
    revision: 2,
    createdByUser: '0000-0002-4115-161X',
    dateCreated: '2020-04-15T07:44:15.559Z',
    dateLastActivity: '2020-04-15T07:44:15.559Z',
    type: 'PROBLEM',
    linkedPublications: [
      '5e94aaae577b8a88890bc805',
    ],
    collaborators: [
      {
        userID: '0000-0002-4115-161X',
        role: 'author',
        status: 'UNCONFIRMED',
      },
    ],
    title: 'Open and Fast access to epidemiological data during the COVID-19 outbreak',
    fundingStatement: 'None',
    coiDeclaration: 'None',
    copyrightLicence: 'CC-BY',
    carriedOut: false,
    text: '<span style="font-size: 12px; font-family: Arial, Helvetica, sans-serif;">Coronavirus disease 2019 (COVID-19) is spreading rapidly across China, and as of Feb 16, 2020, had been reported in 26 countries globally. The availability of accurate and robust epidemiological, clinical, and laboratory data early in an epidemic is important to guide public health decision-making.<div class="dropBlock reference-citations" style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; display: inline; position: relative;"><p style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; display: inline; position: relative;"><br></p></div><p style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; display: inline; position: relative;"><br></p><div class="dropBlock reference-citations" style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; display: inline; position: relative;">Consistent recording of epidemiological information is important to understand transmissibility, risk of geographic spread, routes of transmission, and risk factors for infection, and to provide the baseline for epidemiological modelling that can inform planning of response and containment efforts to reduce the burden of disease. Furthermore, detailed information provided in real time is crucial for deciding where to prioritise surveillance.<p style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; display: inline; position: relative;"><br></p></div><p style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; display: inline; position: relative;"><br></p></span><div class="section-paragraph" style="font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; box-sizing: border-box; margin-top: 10px; margin-bottom: 18px; caret-color: rgb(80, 80, 80); color: rgb(80, 80, 80); font-family: " source="" sans="" pro",="" sans-serif;="" font-size:="" 18px;"=""><span style="font-size: 12px; font-family: Arial, Helvetica, sans-serif;">Line list data are rarely available openly in real time during outbreaks. However, they enable a multiplicity of analyses to be undertaken by different groups, using various models and assumptions, which can help build consensus on robust inference. Parallels exist between this and the open sharing of genomic data.</span><div class="dropBlock reference-citations" style="box-sizing: border-box; display: inline; position: relative;"><sup style="box-sizing: border-box; line-height: 0; position: relative; vertical-align: baseline; top: -0.5em; font-size: 13.5px;"><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30119-5/fulltext#bib2" id="back-bib2" data-db-target-for="bib2-d3353096e170" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib2" style="box-sizing: border-box; background-color: transparent; text-decoration-skip: objects; cursor: pointer; color: rgb(0, 84, 158); text-decoration: none; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: rgb(235, 235, 235);"></a></sup></div></div>',
    keywords: [],
    ratings: [],
    publicationID: '5e949b515706eb67777ae954',
  },
  {
    _id: ObjectId('5e9ad877b6ef8b0e786eb382'),
    status: 'ARCHIVE',
    revision: 1,
    createdByUser: '0000-0002-4115-161X',
    dateCreated: '2020-04-05T11:29:10.625Z',
    dateLastActivity: '2020-04-05T11:29:10.625Z',
    type: 'HYPOTHESIS',
    linkedPublications: [
      '5e89be14e4b4fc6618217452',
    ],
    collaborators: [
      {
        userID: '0000-0002-4115-161X',
        role: 'author',
        status: 'UNCONFIRMED',
      },
    ],
    title: 'Looking at prevalence of co-morbidities in COVID-19 cases allows assessment of risk factors',
    summary: 'Looking at prevalence of co-morbidities in COVID-19 cases allows assessment of risk factors',
    fundingStatement: 'None',
    coiDeclaration: 'None',
    copyrightLicence: 'CC-BY',
    carriedOut: false,
    text: 'Worldwide we now have data from 45,000 patients with COVID-19, which could give insights into the risk factors for poor prognosis.',
    publicationID: '5e89c106e4b4fc6618217454',
  },
  {
    _id: ObjectId('5e9ad8d7b6ef8b0e786eb383'),
    status: 'ARCHIVE',
    revision: 1,
    createdByUser: '0000-0002-4115-161X',
    dateCreated: '2020-04-13T17:14:44.354Z',
    dateLastActivity: '2020-04-13T17:14:44.354Z',
    type: 'HYPOTHESIS',
    linkedPublications: [
      '5e949b515706eb67777ae954',
    ],
    collaborators: [
      {
        userID: '0000-0002-4115-161X',
        role: 'author',
        status: 'UNCONFIRMED',
      },
    ],
    title: 'Creating public and open repositories for COVID data',
    fundingStatement: 'None',
    coiDeclaration: 'None',
    copyrightLicence: 'CC-BY',
    carriedOut: false,
    text: '<p>It should be possible to collate data from a variety of sources, bringing them together into one place and keeping them up to date as a global source data for researchers.</p><p>This data could be used to build evidence for planning, modelling, and epidemiological studies to better inform the public, policy makers, and international organisations and funders as to where and how to improve surveillance, response efforts, and delivery of resources, which are crucial factors in containing the COVID-19 epidemic.\r\nThe epidemic is unfolding rapidly and reports are outdated quickly, so it will be necessary to build computational infrastructure that can handle the large expected increase in case reports. Data sharing will be vital to evaluate and maintain accurate reporting of cases during this outbreak.<br></p>',
    publicationID: '5e949e045706eb67777ae958',
  },
  {
    _id: ObjectId('5e9ad91ab6ef8b0e786eb384'),
    status: 'ARCHIVE',
    revision: 1,
    createdByUser: '0000-0002-4115-161X',
    dateCreated: '2020-04-13T19:03:32.202Z',
    dateLastActivity: '2020-04-13T19:03:32.202Z',
    type: 'PROBLEM',
    linkedPublications: [
      '5e94aaae577b8a88890bc805',
    ],
    collaborators: [
      {
        userID: '0000-0002-4115-161X',
        role: 'author',
        status: 'UNCONFIRMED',
      },
    ],
    title: 'What is the R0 of the COVID-19 virus?',
    fundingStatement: 'None',
    coiDeclaration: 'None',
    copyrightLicence: 'CC-BY',
    carriedOut: false,
    text: '<p>In Wuhan, China, a novel and alarmingly contagious primary atypical (viral) pneumonia broke out in December 2019. It has since been identified as a zoonotic coronavirus, similar to SARS coronavirus and MERS coronavirus and named COVID-19. As of 8 February 2020, 33 738 confirmed cases and 811 deaths have been reported in China.</p><p><br></p><p>The basic reproduction number (R0) is a central concept in infectious disease epidemiology, indicating the risk of an infectious agent with respect to epidemic spread. Calculating it in this new virus is vital to support modelling of the spread of the pandemic.</p>',
    publicationID: '5e94b7845706eb67777ae964',
  }];
